BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7945673)

  • 1. In vitro and in vivo binding of epirubicin to red blood cells and human plasma proteins.
    Bandak S; Czejka M; Schüller J
    Z Naturforsch C J Biosci; 1994; 49(7-8):483-8. PubMed ID: 7945673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Binding of epirubicin to human plasma protein and erythrocytes: interaction with the cytoprotective amifostine].
    Pernkopf I; Tesch G; Dempe K; Kletzl H; Schüller J; Czejka M
    Pharmazie; 1996 Nov; 51(11):897-901. PubMed ID: 9036391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells.
    Bandak S; Czejka M; Schüller J; Schernhammer E
    Arzneimittelforschung; 1995 Feb; 45(2):212-5. PubMed ID: 7710452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of Tienilic acid (Diflurex) to human plasma proteins and erythrocytes.
    Plessas C; Benakis A
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):107-12. PubMed ID: 7398676
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine.
    Czejka M; Bandak S; Simon D; Schüller J; Weiss C; Schernhammer E
    Z Naturforsch C J Biosci; 1995; 50(7-8):565-70. PubMed ID: 7546045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
    Zini R; Morin D; Jouenne P; Tillement JP
    Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of minaprine to human serum proteins and erythrocytes.
    Barré J; Houin G; Jeanniot JP; Coirre C; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(1):1-9. PubMed ID: 3957500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binedaline binding to plasma proteins and red blood cells in humans.
    Morin D; Zini R; Ledewyn S; Colonna JP; Czajka M; Tillement JP
    J Pharm Sci; 1985 Jul; 74(7):727-30. PubMed ID: 4032243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood components.
    Ramanathan-Girish S; Boroujerdi M
    J Pharm Pharmacol; 2001 Jun; 53(6):815-21. PubMed ID: 11428657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro binding of MX2 (KRN8602) and epirubicin to human plasma protein.
    Zhang WZ; Cosolo W; Zalcberg J
    Pharmacology; 1997 Dec; 55(6):279-84. PubMed ID: 9413856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of pyrimethamine to human plasma proteins and erythrocytes.
    Rudy AC; Poynor WJ
    Pharm Res; 1990 Oct; 7(10):1055-60. PubMed ID: 2281036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding in vitro of pipequaline (45319 RP) onto plasma proteins and blood cells in man.
    Essassi D; Zini R; Hamberger C; Urien S; Rougeot C; Uzan A; Tillement JP
    Biochem Pharmacol; 1987 Oct; 36(20):3501-7. PubMed ID: 2890351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protein binding of fenpentadiol-14C (2-méthyl-4-p-chlorophényl-2,4-pentane-diol) in vivo and in vitro (author's transl)].
    Dormard Y; Plessas C; Benakis A
    J Pharmacol; 1982; 13(1):11-20. PubMed ID: 6175856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
    Pibouin M; Zini R; Nguyen P; Renouard A; Tillement JP
    Br J Dermatol; 1987 Aug; 117(2):207-15. PubMed ID: 3651341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.